Go Pro

Allergy Therapeutics (AGY) Stock Chart & Stock Price History

Allergy Therapeutics logo
GBX 5 +0.25 (+5.26%)
As of 09/11/2026 06:06 AM Eastern

Allergy Therapeutics Stock Price Performance

5 Day
Performance
-7.37%
1 Month
Performance
-4.58%
3 Month
Performance
-37.26%
Year-To-Date
Performance
-55.36%
1 Year
Performance
-39.76%
5 Year
Performance
-85.16%

AGY Stock Chart for Saturday, September, 12, 2026

The Allergy Therapeutics (AGY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 39.76%, with a year-to-date return of -55.36%. In the past month, the stock has decreased 4.58%, reflecting recent market activity.

As of the latest close, Allergy Therapeutics traded at GBX 5 with a market cap of £316.63 million and volume of 488,345 shares. Five years ago, the stock traded at GBX 33.69, representing a 85.16% decrease over that period. At the time, it had a market cap of £216.20 million and a volume of 208,679 shares. View the advanced AGY chart on TradingView.

Receive AGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Allergy Therapeutics Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
09/11/2026GBX 5GBX 5GBX 5GBX 4.75488,345 shs£316.63 million
09/10/2026GBX 4.98GBX 5
+0.50%
GBX 5.50GBX 4.50479,869 shs£316.63 million
09/09/2026GBX 4.93GBX 4.98
+1.02%
GBX 5.50GBX 4.50135,582 shs£315.04 million
09/08/2026GBX 5GBX 4.93
-1.50%
GBX 5.50GBX 4.51558,574 shs£311.88 million
09/07/2026GBX 5.40GBX 5
-7.37%
GBX 5.50GBX 5438,312 shs£316.63 million
09/04/2026GBX 5.50GBX 5.40
-1.85%
GBX 5.42GBX 5.213,164 shs£341.83 million
09/03/2026GBX 5.42GBX 5.50
+1.48%
GBX 5.50GBX 58.92 million shs£348.29 million
09/02/2026GBX 5.55GBX 5.42
-2.34%
GBX 6GBX 545,843 shs£343.22 million
09/01/2026GBX 5.70GBX 5.55
-2.63%
GBX 5.55GBX 5.2212,875 shs£351.46 million
08/31/2026GBX 5.70GBX 5.70GBX 5.70GBX 5.20289,651 shs£360.95 million
08/28/2026GBX 5.70GBX 5.70GBX 5.70GBX 5.20289,651 shs£360.95 million
08/27/2026GBX 5.60GBX 5.70
+1.79%
GBX 6GBX 5.20621,223 shs£360.95 million
08/26/2026GBX 5.60GBX 5.60GBX 5.75GBX 5.50140,852 shs£354.62 million
08/25/2026GBX 5.60GBX 5.60GBX 5.75GBX 5.5086,941 shs£354.62 million
08/24/2026GBX 5.10GBX 5.60
+9.80%
GBX 6GBX 5.6037,515 shs£354.62 million
08/21/2026GBX 5.39GBX 5.10
-5.38%
GBX 5.48GBX 5.10443,731 shs£322.96 million
08/20/2026GBX 5.50GBX 5.39
-2.00%
GBX 5.39GBX 5.08220,000 shs£341.32 million
08/19/2026GBX 5.29GBX 5.50
+4.05%
GBX 5.50GBX 5.254,137 shs£348.29 million
08/18/2026GBX 5.28GBX 5.29
+0.21%
GBX 5.39GBX 5.2519,451 shs£334.74 million
08/17/2026GBX 5.42GBX 5.28
-2.68%
GBX 5.50GBX 5.2827,183 shs£334.04 million
08/14/2026GBX 5.43GBX 5.42
-0.09%
GBX 5.50GBX 5.40201,802 shs£343.22 million
08/13/2026GBX 5.24GBX 5.43
+3.53%
GBX 5.43GBX 5.198.79 million shs£332.46 million
08/12/2026GBX 5.18GBX 5.24
+1.26%
GBX 5.25GBX 5.11395,832 shs£331.83 million
08/11/2026GBX 5.70GBX 5.18
-9.21%
GBX 5.69GBX 5525,312 shs£327.71 million

This page (LON:AGY) was last updated on 9/11/2026 by MarketBeat.com Staff.
From Our Partners